Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Walgreens Boots Alliance (DE:W8A)
XETRA:W8A
RESEARCH TOOLSreports
Holding DE:W8A?
Track your performance easily
W8A Stock Chart & Stats
Day’s Range― - ―
52-Week Range€7.40 - €21.84
Previous CloseN/A
Volume364.00
Average Volume (3M)17.42K
Market Cap
$9.66B
Enterprise Value€38.64B
Total Cash (Recent Filing)$3.30B
Total Debt (Recent Filing)$12.68B
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Mar 27, 2025EPS Estimate
0.51Last Dividend Ex-Date
Nov 18, 2024Dividend Yield8.52%
Share Statistics
EPS (TTM)-9.42
Shares Outstanding864,153,440
10 Day Avg. Volume24,899
30 Day Avg. Volume17,424
Standard Deviation0.10
R-Squared0.12
Alpha-0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.07
Price to Cash Flow (P/CF)-18.30
P/FCF Ratio0.00
Enterprise Value/Market Cap4.00
Enterprise Value/Revenue0.26
Enterprise Value/Gross Profit1.46
Enterprise Value/Ebitda-3.38
Forecast
1Y Price Target
€11.19Price Target Upside2.80% Upside
Rating ConsensusHold
Number of Analyst Covering10
Walgreens Boots Alliance News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFirst-quarter sales increased by 7.5% year-over-year, driven by improvements in the U.S. segment and strong performance in pharmacy and healthcare.
Operational StrategyThe company continues to execute on its transformational consumer-centric healthcare strategy, aiming to provide a better experience for customers, improve outcomes and lower overall healthcare costs.
Strategic DevelopmentsAnalyst views a potential sale of Boots as helping to delever the company while focusing on its core U.S. Healthcare assets.
Bears Say
Financial ChallengesWalgreens reiterated a fairly wide EPS guidance range, indicating uncertainty in future earnings.
Legal ConcernsThe DOJ headlines serve as a reminder that the opioid overhang is still out there despite numerous settlements by Walgreens and other participants.
Operational UncertaintyLong term numbers are very much an unknown, with operational variability likely impacting the outlook.
---
Ownership Overview
17.72% Insiders
13.08% Mutual Funds
0.03% Other Institutional Investors
42.67% Public Companies and Individual Investors
Website Traffic
The estimated number of people who visited one or more of the websites owned by Walgreens Boots Alliance
Desktop Users
Mobile Users
W8A FAQ
What was Walgreens Boots Alliance’s price range in the past 12 months?
Walgreens Boots Alliance lowest stock price was €7.40 and its highest was €21.84 in the past 12 months.
What is Walgreens Boots Alliance’s market cap?
Walgreens Boots Alliance’s market cap is $9.66B.
When is Walgreens Boots Alliance’s upcoming earnings report date?
Walgreens Boots Alliance’s upcoming earnings report date is Mar 27, 2025 which is in 55 days.
How were Walgreens Boots Alliance’s earnings last quarter?
Walgreens Boots Alliance released its earnings results on Jan 10, 2025. The company reported €0.491 earnings per share for the quarter, beating the consensus estimate of €0.364 by €0.127.
Is Walgreens Boots Alliance overvalued?
According to Wall Street analysts Walgreens Boots Alliance’s price is currently Undervalued.
Does Walgreens Boots Alliance pay dividends?
Walgreens Boots Alliance pays a Quarterly dividend of €0.952 which represents an annual dividend yield of 8.52%. See more information on Walgreens Boots Alliance dividends here
What is Walgreens Boots Alliance’s EPS estimate?
Walgreens Boots Alliance’s EPS estimate is 0.51.
How many shares outstanding does Walgreens Boots Alliance have?
Walgreens Boots Alliance has 864,153,440 shares outstanding.
What happened to Walgreens Boots Alliance’s price movement after its last earnings report?
Walgreens Boots Alliance reported an EPS of €0.491 in its last earnings report, beating expectations of €0.364. Following the earnings report the stock price went up 23.039%.
Which hedge fund is a major shareholder of Walgreens Boots Alliance?
Currently, no hedge funds are holding shares in DE:W8A
---
Walgreens Boots Alliance Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€11.19 (2.80% Upside)
€11.19 (2.80% Upside)
Blogger Sentiment
Neutral
DE:W8A Sentiment 54%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.59%
12-Months-Change
Fundamentals
Return on Equity
-60.05%
Trailing 12-Months
Asset Growth
-19.72%
Trailing 12-Months
Company Description
Walgreens Boots Alliance
Retail pharmacy leader Walgreens Boots Alliance (NASDAQ:WBA) operates through its namesake brand Walgreens in the U.S. and Boots in the U.K. In addition, it owns retail and business brands including the No7 Beauty Company, Duane Reade, Ahumada in Chile, and Benavides in Mexico. The company also targets equity investments in healthcare, pharmacy, and retail and has a presence in over 25 countries with more than 450,000 employees.
---
W8A Company Deck
---
W8A Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong sales growth across all segments, improved free cash flow, and positive performance in the pharmacy and healthcare segments. However, it also noted challenges with declining retail sales in the U.S. and a significant decline in adjusted EPS. Despite these challenges, the company remains focused on executing its turnaround strategy.Read More>---
W8A Revenue Breakdown
78.41% U.S. Retail Pharmacy
15.95% International
5.65% U.S. Healthcare
---
W8A Stock 12 Month Forecast
Average Price Target
€11.19
▲(2.80% Upside)
Technical Analysis
Best Analysts Covering W8A
1 Year
1 Year Success Rate
8/11 ratings generated profit
1 Year Average Return
+22.29%
reiterated a sell rating 21 hours ago
Copying Erin Wright's trades and holding each position for 1 Year would result in 72.73% of your transactions generating a profit, with an average return of +22.29% per trade.
---